Participants 52 119 6
type 2 diabetic patients with late failure of sulphonylurea therapy
Participants 229 349 5
patients with type 2 diabetes receiving exogenous insulin due to secondary failure of maximum dose sulphonylurea therapy
Participants 444 665 8
48 type 2 diabetic patients with late-term failure following at least 3 years of sulphonylurea therapy requiring additional insulin therapy to determine the impact of acarbose on glycaemic control and insulin requirements
Participants 1941 1965 4
type 2 diabetic patients
